EditorÐWe read with interest the review article on obstetric epidurals and chronic adhesive arachnoiditis by Rice and colleagues.
1 This article addresses most of the issues relevant to anaesthetists and pain specialists. However, we would like to draw attention to the complications associated with long-term use of neuroaxial opioids. The authors state that a review of the literature by a panel of experts in chronic pain relief noted that the intrathecal administration of morphine and fentanyl at clinically effective concentrations appeared to be safe. 2 To our knowledge, there is no evidence for chronic adhesive arachnoiditis after longterm opioid administration from human or animal data. However, catheter-tip in¯ammatory masses (granulomas) are increasingly reported in humans receiving long-term intrathecal opioid drugs.
3 4 These are sterile masses consisting of in¯ammatory cells attached to the catheter tip that may or may not result in spinal cord compression. Pathophysiological causes associated with their formation incidence are: There is evidence to suggest that opioids can incite an in¯ammatory response in the brain or spinal cord tissues. 6 The postulated mechanisms for formation are: (i) The mitogen-activated protein kinase cascade where morphine can act as a mitogen, thus activating lymphocyte activity.
(ii) Morphine enhancing cytokine formation, leading to an in¯ammatory cell response.
(ii) Opioids causing endothelial cells, granulocytes and monocytes to release nitric oxide, which in turn leads to monocyte migration in the presence of mesangial cells.
The development of an in¯ammatory mass should be suspected if a patient presents with progressive loss of analgesic ef®cacy despite dose escalation, accompanied by a change in character, quality or intensity of the pain, drug withdrawal symptoms, sensory changes (e.g. numbness, tingling, burning), hyperaesthesia, hyperalgesia, sleep disturbances, bowel and/or bladder dysfunction, myelopathy, conus syndrome, gait disturbances/dif®culty ambulating, or paraparesis/ paralysis.
In asymptomatic or minimally symptomatic catheter tipassociated in¯ammatory masses, the opioid therapy could be effectively continued by changing to a different opioid drug, substituting the opioid for an infusion of normal saline, or discontinuation of treatment, altogether along with close neurological monitoring. Catheter explantation is not necessary. Regular follow-up and maintaining an index of suspicion will permit early diagnosis and minimally invasive treatment of these masses, preventing neurological damage.
Whenever possible, positioning the catheter in the lumbar thecal sac, keeping the daily dose of opioid as low as possible, and using lower concentrations of preservative-free opioids may reduce the incidence of such in¯ammatory masses.
A. P. Gulve S. Eldabe Middlesbrough, UK EditorÐI read with interest, but concern, the review article by Rice and colleagues.
1 Interest because much of my working week is spent in dealing with chronic backache, and concern because the reassurance this article purports to offer to pregnant women asking about the risks of arachnoiditis after an epidural, I believe is insuf®ciently grounded in wisdom, or worse still, may be misleading. The thrust of the article describes the intrathecal sequelae of either epidurally or intrathecally placed solutions. Almost nothing was said of the epidural space. The implication is that if intrathecal changes cannot be detected from correct epidural placement of accepted non-toxic solution, in the presence of inconclusive studies on back pain, all must be well; women in labour can be reassured. I disagree. Epidural cannulation and catheterization gives rise to epidural ®brosis and upon this topic we are not in a position to reassure anyone.
After a number of publications reporting that repeated epidural anaesthesia is unreliable, 7 8 Igarashi and colleagues assessed the cephalad spread of analgesia in 491 patients undergoing epidural anaesthesia at the L2±3 or L3±4 interspace. 9 Patients were classi®ed into one of three groups based on the number of previous lumbar epidural procedures: none (Group 1, n=339), one (Group 2, n=82), and two or more (Group 3, n=70). Cephalad spread of analgesia was signi®cantly greater in Group 1 than in Groups 2 or 3, regardless of the puncture site. Examination of the epidural space took place using a¯exible extraduroscope in 32 patients who were excluded from the analysis of spread. Epiduroscopy demonstrated patency in patients with no history of prior lumbar epidural anaesthesia, but in patients who had received epidural anaesthesia one or more times there were clear aseptic in¯ammatory changes, including proliferation of connective tissue, adhesions between the dura mater and the ligamentum¯avum, and granulation tissue within the ligamentum avum. It was concluded that epidural anaesthesia might cause aseptic in¯ammatory changes in the extradural space which affects the spread of analgesia.
Kitamura and colleagues divided patients into a control group of 10 who had not previously received epidural analgesia, and 8 who had had epidural analgesia for 7±14 days. 10 The epidural space was observed through a 0.75 mm epiduroscope passed through a 17 gauge Tuohy needle. Adverse reactions such as haemorrhage or congestion with engorgement were observed in four patients in the epidural group. Five in the epidural group experienced pain when the epiduroscope was passed. No such ®ndings were found in those with a previously unentered epidural space.
Wulf and Striepling reported post-mortem ®ndings in subjects who had received continuous postoperative analgesia before death. 11 In®ltration of the dura and epidural tissues with lymphocytes and plasma cells was found along with bacterial contamination in 7 out of 10 patients. That these gross pathological changes in the epidural space can occur after epidural catheterization is not in doubt. But apart from probably affecting subsequent epidural ef®cacy, do they matter?
Crude imaging estimates of the amount of epidural ®brosis vs symptoms of back pain invariably fails, as does the relationship of the amount of ®brosis to the extent of direct epidural space trauma, e.g. at operation. 12 13 In the failed back surgery syndrome (FBSS), some authors have assigned chronic pain to the presence of scar tissue itself, apportioning 8±14% of patients with a FBSS to this ®nding. 14 15 Others reject that pain is produced by ®brosis, using as evidence the grossly similar anatomical mass of scar between symptomatic and asymptomatic patients. This argument ignores the potential pathophysiological effects of nerve root tethering and compression.
In examining epidural scar tissue, magnetic resonance imaging is very disappointing, even with gadolinium enhancement; spinal endoscopy is far more sensitive. 16 17 Epiduroscopic changes associated with long-term backache frequently reveal the exact same changes described by Igarashi and colleagues after epidural catheterization. 16 17 There is a proliferation of connective tissue, adhesions between the dura mater and the ligamentum¯avum and epidural granulation tissue. In addition, nerve roots appear either abnormally avascular or else hyperaemic and are often devoid of the normally marked, transmitted pulsation from the dural sac. Nerve roots embedded in scar tissue may be markedly tender to touch and frequently elicit from the patient exact descriptions of typical pain reproduction, the validity of which in relation to chronic pain has been con®rmed in a number of clinical settings. 16 17 The dura, a heavily (anteriorly) innervated structure, 18 if tethered by epidural ®brosis, can be a potent source of diffuse back pain, probably partly attributable to impairment of its ability to stretch with back and hip movements. 19 Interestingly, in patients with chronic back pain after intervertebral disc degeneration with or without surgery, spinal endoscopy, despite revealing a highly abnormal epidural space, if dural puncture is made and the intrathecal space is examined, normal anatomy is nearly always found.
It is a matter of concern to me that these changes within the epidural space, which follow seemingly innocuous epidural catheterization and which are the same or very similar to changes in patients with chronic severe back pain, seem to be overlooked. Although the step of connecting these changes to long-term pain is not proven, it would appear unwise to ignore them.
It is not the purpose of this letter to attempt a review of the demographic evidence for or against chronic back pain after obstetric epidurals. There are worries 20±22 that statistically and methodologically are very dif®cult to discount. How do you prove the non-existence of anything?
In my pain clinic, I see patients with back pain, for no identi®able reason, which follows epidural catheterization for various surgical or obstetric indications, and who attribute their problem, anatomically and chronologically, exactly to that event. In the light of the above, I ®nd myself at a loss to either attribute their pain to the epidural or assure them they are mistaken.
The bene®ts of excellent afferent block in perioperative medicine, especially for un®t patients for major surgery, are central to optimal outcomes, 23 and I would not wish these worries to detract from that great advance. I do, however, have concerns in using epidural anaesthesia in obstetric practice for young, healthy women with short-lived pain and a non at-risk fetus. There are alternatives to entering the epidural space. 24 I suggest that if we want to give honest information we should say something like`your epidural may cause scarring in your back, which might affect the quality of subsequent epidurals, but we don't (yet) know if it could be associated with back pain'.
J. Richardson Bradford, UK
EditorÐWe thank you for the opportunity to reply to the letter of Gulve and colleagues, and that of Richardson. We are pleased that our review article has stimulated debate on the in¯ammatory consequences of instrumentation of the epidural space. We believe this is an important debate to have.
We do not dispute that long-term epidural catheterization and the long-term use of neuraxial opioids can lead to the formation of in¯ammatory mediators and ®brosis of the epidural space. We agree with Richardson that the indisputable epiduroscopic evidence that there are in¯ammatory changes in the epidural space after its cannulation, both long-term 10 and short-term 9 , is of concern. We are also aware of studies suggesting that epidural spread of local anaesthetic is unreliable on repeated epidurals. 7 25 However, epiduroscopic studies show that ®brous tissue is present in the majority of epidural spacesÐmany more in number than patients who have had epidural interventions, or experience unreliable epidural block.
26±29 Spinaloscopy also shows asymptomatic subarachnoid ®brous structures. 30 It is dif®cult to determine the association of these adhesions with long-term pain. We are interested that Richardson has not found abnormal intrathecal spaces in those patients found to have a highly abnormal epidural space.
It may well be that epiduroscopy is a more sensitive tool for detecting epidural adhesions in those presenting with the relevant symptomatology, but we can ®nd no reports of the sensitivity of spinaloscopy in detecting chronic adhesive arachnoiditis. We based our de®nition on MRI evidence because this is a more readily available investigation and has a proven track record for detecting chronic adhesive arachnoiditis.
Our remit on writing the article`obstetric epidurals and chronic adhesive arachnoiditis' 1 was very speci®cÐto determine whether the short-term use of epidurals (usually <24 h), as used in modern UK obstetric practice led to in¯ammatory changes in the subarachnoid space, which cause the syndrome chronic adhesive arachnoiditis, as de®ned in our article. We were unable to ®nd any convincing evidence that this is the case. After initial concerns that obstetric epidurals may lead to long-term back pain, there are now robust prospective randomized controlled trials to show that this is not the case. 21 31 Women request epidural analgesia during labour because they ®nd this short-term pain unacceptably distressing, often despite using other methods of pain relief. Serious psychological sequelae can occur in women denied effective pain relief in labour.
32±34. In this day and age, we feel that we have a duty to alleviate such pain with the most effective method available, when we are requested to do so. Although there is some evidence of post-cannulation in¯ammation and ®brosis in the epidural space, particularly with long-term use of epidurals, we still cannot ®nd any good evidence to support the claim that short-term obstetric epidurals lead to chronic adhesive arachnoiditis. 
